Monte Rosa Therapeutics (GLUE) Current Deferred Revenue (2023 - 2026)
Monte Rosa Therapeutics (GLUE) recorded Current Deferred Revenue of $22.1 million in Q2 2026, up 20.1% from $18.41 million a year earlier but down 33.1% from the prior quarter.
Powered by 
Analysis
Monte Rosa Therapeutics (GLUE) Current Deferred Revenue (2023 - 2026) Analysis & Trends
At the end of FY2025, Monte Rosa Therapeutics reported Current Deferred Revenue of $29.57 million, down 74.8% from FY2024.
- Across earlier years, Current Deferred Revenue came in at $117.23 million in FY2024 (+563.2%) and $17.68 million in FY2023.
- Quarterly Current Deferred Revenue has ranged from $17.68 million in Q4 2023 to $117.23 million in Q4 2024 over the past five years.
- On a year-over-year basis, Current Deferred Revenue rose in five of the last seven quarters, with growth averaging 84.9%.
- Per Business Quant, the preceding three quarters came in at $33.06 million (Q1 2026), $29.57 million (Q4 2025) and $24.79 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Monte Rosa Therapeutics | 1.02 Bn | 428.56 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.10 Mn |
| Mar 31, 2026 | 33.06 Mn |
| Dec 31, 2025 | 29.57 Mn |
| Sep 30, 2025 | 24.79 Mn |
| Jun 30, 2025 | 18.41 Mn |
| Mar 31, 2025 | 32.58 Mn |
| Dec 31, 2024 | 117.23 Mn |
| Sep 30, 2024 | 18.92 Mn |
| Jun 30, 2024 | 19.65 Mn |
| Mar 31, 2024 | 20.41 Mn |
| Dec 31, 2023 | 17.68 Mn |
API Access
Monte Rosa Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=GLUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "GLUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=GLUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();